Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.
|
21382177 |
2011 |
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
|
16611303 |
2006 |
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
Biomarker
|
disease |
BEFREE |
Caspase 10, a representative of the caspase family of proteases, which plays a central role in the execution of apoptosis, is defect in autoimmune lymphoproliferative syndrome type II (ALPS II).
|
11397650 |
2001 |
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
|
10412980 |
1999 |
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
|
10412980 |
1999 |
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Moreover, the caspase-10 L285F and A414V mutants, found in autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma, respectively, regulated this necrosis.
|
27799292 |
2017 |
Lymphoma, Non-Hodgkin, Familial
|
0.620 |
Biomarker
|
disease |
BEFREE |
Caspase-10 is an initiation-phase caspase, and somatic mutation of CASP10 that encodes caspase-10 has been found in non-Hodgkin's lymphoma and gastric carcinoma.
|
20025484 |
2010 |
Lymphoma, Non-Hodgkin, Familial
|
0.620 |
GeneticVariation
|
disease |
UNIPROT |
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas.
|
12010812 |
2002 |
Lymphoma, Non-Hodgkin, Familial
|
0.620 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of stomach
|
0.610 |
GeneticVariation
|
disease |
BEFREE |
Overall, three of 99 gastric cancers (3%) were found to have the caspase-10 mutations, which were identified in the coding regions of the death effector domain (codon 147) and the p17 large protease domain (codons 257 and 410), whereas no mutation was detected in caspase-8.
|
11973654 |
2002 |
Malignant neoplasm of stomach
|
0.610 |
CausalMutation
|
disease |
CGI |
|
|
|
Malignant neoplasm of stomach
|
0.610 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of stomach
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Stomach Neoplasms
|
0.600 |
Biomarker
|
group |
CTD_human |
|
|
|
Stomach Neoplasms
|
0.600 |
CausalMutation
|
group |
CLINVAR |
|
|
|
Stomach Neoplasms
|
0.600 |
CausalMutation
|
group |
CGI |
|
|
|
Lymphoma, Non-Hodgkin
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
Moreover, the caspase-10 L285F and A414V mutants, found in autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma, respectively, regulated this necrosis.
|
27799292 |
2017 |
Lymphoma, Non-Hodgkin
|
0.540 |
Biomarker
|
disease |
BEFREE |
Caspase-10 is an initiation-phase caspase, and somatic mutation of CASP10 that encodes caspase-10 has been found in non-Hodgkin's lymphoma and gastric carcinoma.
|
20025484 |
2010 |
Lymphoma, Non-Hodgkin
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls).
|
17071630 |
2007 |
Lymphoma, Non-Hodgkin
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that the inactivating mutations of the CASP10 gene might lead to the loss of its apoptotic function and contribute to the pathogenesis of some human NHLs.
|
12010812 |
2002 |
Lymphoma, Non-Hodgkin
|
0.540 |
GeneticVariation
|
disease |
LHGDN |
These data suggest that the inactivating mutations of the CASP10 gene might lead to the loss of its apoptotic function and contribute to the pathogenesis of some human NHLs.
|
12010812 |
2002 |
Lymphoma, Non-Hodgkin
|
0.540 |
Biomarker
|
disease |
CTD_human |
|
|
|